Skip to main content

Therapeutic Areas


Eurofins Viracor BioPharma is a unique clinical development partner with proven expertise in custom assay design and validation across a broad array of industry-leading analytical platforms.  We partner with our clients to support their oncology-focused translational research with innovative technologies and integrated testing solutions that provide the flexibility and scalability to help advance their pioneering treatments to market faster.


Molecular & genomics bioassay capabilities for clinical immunotherapy studies:

  • Predictive biomarker assays (whole exome or RNA sequencing)
  • qPCR or microarray-based RNA expression assays
  • Gene expression profiles for detecting and characterizing mutations/biomarkers in cancer cells with Nanostring technology.
  • Comprehensive targeted NGS panels or tumor profiling assays to detect known and emerging biomarkers, and measure tumor mutational burden

We also offers a comprehensive and diverse technology portfolio, together with in-house expertise, to provide custom assay design, validation, and analysis for any supported platform including:

  • PCR, ddPCR, Sanger
  • NGS (WGS, WES, RNASeq, somatic testing, and custom panels
  • Nanostring (non-PCR gene  expression)
  • Flow Cytometry
Back to top